CY1111750T1 - Νευροτροφικοι παραγοντες - Google Patents
Νευροτροφικοι παραγοντεςInfo
- Publication number
- CY1111750T1 CY1111750T1 CY20111100765T CY111100765T CY1111750T1 CY 1111750 T1 CY1111750 T1 CY 1111750T1 CY 20111100765 T CY20111100765 T CY 20111100765T CY 111100765 T CY111100765 T CY 111100765T CY 1111750 T1 CY1111750 T1 CY 1111750T1
- Authority
- CY
- Cyprus
- Prior art keywords
- neurotrophic factors
- neublastin
- polypeptides
- methods
- antibodies
- Prior art date
Links
- 108010025020 Nerve Growth Factor Proteins 0.000 title 1
- 102000007072 Nerve Growth Factors Human genes 0.000 title 1
- 239000003900 neurotrophic factor Substances 0.000 title 1
- 102100026376 Artemin Human genes 0.000 abstract 3
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/4756—Neuregulins, i.e. p185erbB2 ligands, glial growth factor, heregulin, ARIA, neu differentiation factor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Public Health (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/804,615 US20020055467A1 (en) | 1998-07-06 | 2001-03-12 | Novel neurotrophic factors |
| EP07120461A EP1930439B1 (en) | 2001-03-12 | 2002-03-12 | Neurotrophic factors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1111750T1 true CY1111750T1 (el) | 2015-10-07 |
Family
ID=25189406
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20111100765T CY1111750T1 (el) | 2001-03-12 | 2011-08-10 | Νευροτροφικοι παραγοντες |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20020055467A1 (enExample) |
| EP (2) | EP1373503B1 (enExample) |
| JP (2) | JP3738008B2 (enExample) |
| CN (1) | CN1268744C (enExample) |
| AT (2) | ATE378353T1 (enExample) |
| AU (1) | AU2002240943B2 (enExample) |
| CA (1) | CA2440767C (enExample) |
| CY (1) | CY1111750T1 (enExample) |
| DE (1) | DE60223511T2 (enExample) |
| DK (2) | DK1930439T3 (enExample) |
| ES (2) | ES2296899T3 (enExample) |
| NZ (1) | NZ528790A (enExample) |
| PT (2) | PT1373503E (enExample) |
| SI (2) | SI1373503T1 (enExample) |
| WO (1) | WO2002072826A2 (enExample) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6593133B1 (en) * | 1998-07-06 | 2003-07-15 | Nsgene A/S | Neurotrophic factors |
| KR100773776B1 (ko) * | 1998-07-14 | 2007-11-12 | 얀센 파마슈티카 엔.브이. | 신경친화성 성장 인자 |
| IL156559A0 (en) * | 2000-12-22 | 2004-01-04 | Genentech Inc | New use of artemin, a member of the gdnf ligand family |
| US7442370B2 (en) * | 2001-02-01 | 2008-10-28 | Biogen Idec Ma Inc. | Polymer conjugates of mutated neublastin |
| US7276580B2 (en) * | 2001-03-12 | 2007-10-02 | Biogen Idec Ma Inc. | Neurotrophic factors |
| EP1395279B1 (en) * | 2001-03-28 | 2011-10-05 | Biogen Idec MA Inc. | Use of neublastin polypeptides for treating neuropathic pain |
| US7112321B2 (en) * | 2001-12-19 | 2006-09-26 | Genzyme Corporation | Adeno-associated virus-mediated delivery of GDNF to skeletal muscles |
| JP4571776B2 (ja) * | 2002-11-05 | 2010-10-27 | Ｊｘ日鉱日石エネルギー株式会社 | 潤滑油組成物 |
| BRPI0407170A (pt) * | 2003-01-31 | 2006-02-21 | Biogen Idec Inc | conjugados de polìmero de neoblastina mutada |
| CA2864810A1 (en) * | 2003-04-18 | 2004-11-04 | Biogen Idec Ma, Inc. | Polymer-conjugated glycosylated neublastin |
| US7601518B2 (en) * | 2003-06-10 | 2009-10-13 | Nsgene A/S | Secretion of neublastin |
| US7598059B2 (en) * | 2003-10-02 | 2009-10-06 | Biogen Idec Ma Inc. | Neublastin expression constructs |
| AU2004283053A1 (en) | 2003-10-20 | 2005-05-06 | Nsgene A/S | In vivo gene therapy of Parkinson's Disease |
| AU2005277227B2 (en) | 2004-08-19 | 2011-10-06 | Biogen Ma Inc. | Refolding transforming growth factor beta family proteins |
| GEP20115196B (en) * | 2004-08-19 | 2011-04-11 | Biogen Idec Inc | Neublastin variants |
| WO2007042040A2 (en) * | 2005-10-11 | 2007-04-19 | Ns Gene A/S | TREATMENT OF RETINOPATHIES USING GFRα3 AGONISTS |
| TWI501774B (zh) * | 2006-02-27 | 2015-10-01 | Biogen Idec Inc | 神經性病症之治療 |
| US20100056440A1 (en) * | 2006-03-01 | 2010-03-04 | Biogen Idec Ma Inc. | Compositions and methods for administering gdnf ligand family proteins |
| AU2008247637B2 (en) | 2007-05-01 | 2013-12-05 | Biogen Ma Inc. | Compositions and methods for increasing vascularization |
| WO2009020964A2 (en) * | 2007-08-08 | 2009-02-12 | Biogen Idec Ma Inc. | Anti-neublastin antibodies and uses thereof |
| US20100247437A1 (en) * | 2007-10-01 | 2010-09-30 | Vgx Pharmaceuticals, Llc | Materials and methods for the delivery of biomolecules to cells of an organ |
| EP2621512B1 (en) * | 2010-10-01 | 2016-04-06 | NsGene A/S | Use of meteorin for the treatment of allodynia, hyperalgesia, spontaneous pain and phantom pain |
| CN112533642A (zh) * | 2018-05-17 | 2021-03-19 | 赫利世弥斯株式会社 | 治疗与化疗诱发的周围神经病变相关的神经性疼痛 |
| AU2022278242B2 (en) | 2021-05-18 | 2024-11-14 | Ltt Bio-Pharma Co., Ltd. | Pharmaceutical composition for treating or preventing disorder associated with administration of anticancer agent |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6184200B1 (en) * | 1995-09-28 | 2001-02-06 | Amgen Inc. | Truncated glial cell line-derived neurotrophic factor |
| TR199802252T2 (xx) | 1996-05-08 | 1999-02-22 | Biogen, Inc | N�ral ve renal geli�menin uyar�lmas� i�in ret ligand� (RetL) |
| WO2000073348A2 (en) * | 1999-06-02 | 2000-12-07 | Genentech, Inc. | Methods and compositions for inhibiting neoplastic cell growth |
| US6593133B1 (en) * | 1998-07-06 | 2003-07-15 | Nsgene A/S | Neurotrophic factors |
| US6284540B1 (en) * | 1998-09-29 | 2001-09-04 | Washington University | Artemin, a novel neurotrophic factor |
| EP1137774A2 (en) * | 1998-12-09 | 2001-10-04 | Amgen Inc. | Grnf4, a gdnf-related neurotrophic factor |
-
2001
- 2001-03-12 US US09/804,615 patent/US20020055467A1/en not_active Abandoned
-
2002
- 2002-03-12 PT PT02706759T patent/PT1373503E/pt unknown
- 2002-03-12 AT AT02706759T patent/ATE378353T1/de active
- 2002-03-12 DE DE60223511T patent/DE60223511T2/de not_active Expired - Lifetime
- 2002-03-12 EP EP02706759A patent/EP1373503B1/en not_active Expired - Lifetime
- 2002-03-12 NZ NZ528790A patent/NZ528790A/en not_active IP Right Cessation
- 2002-03-12 SI SI200230656T patent/SI1373503T1/sl unknown
- 2002-03-12 SI SI200230954T patent/SI1930439T1/sl unknown
- 2002-03-12 DK DK07120461.4T patent/DK1930439T3/da active
- 2002-03-12 AT AT07120461T patent/ATE509103T1/de active
- 2002-03-12 WO PCT/EP2002/002691 patent/WO2002072826A2/en not_active Ceased
- 2002-03-12 DK DK02706759T patent/DK1373503T3/da active
- 2002-03-12 PT PT07120461T patent/PT1930439E/pt unknown
- 2002-03-12 AU AU2002240943A patent/AU2002240943B2/en not_active Ceased
- 2002-03-12 CN CNB028097858A patent/CN1268744C/zh not_active Expired - Fee Related
- 2002-03-12 ES ES02706759T patent/ES2296899T3/es not_active Expired - Lifetime
- 2002-03-12 CA CA2440767A patent/CA2440767C/en not_active Expired - Fee Related
- 2002-03-12 EP EP07120461A patent/EP1930439B1/en not_active Expired - Lifetime
- 2002-03-12 JP JP2002571881A patent/JP3738008B2/ja not_active Expired - Fee Related
- 2002-03-12 ES ES07120461T patent/ES2366610T3/es not_active Expired - Lifetime
-
2005
- 2005-02-02 JP JP2005027109A patent/JP2005198656A/ja not_active Withdrawn
-
2011
- 2011-08-10 CY CY20111100765T patent/CY1111750T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP3738008B2 (ja) | 2006-01-25 |
| CA2440767C (en) | 2012-05-29 |
| AU2002240943A2 (en) | 2002-09-24 |
| ATE509103T1 (de) | 2011-05-15 |
| CN1509333A (zh) | 2004-06-30 |
| EP1930439B1 (en) | 2011-05-11 |
| NZ528790A (en) | 2004-06-25 |
| EP1930439A1 (en) | 2008-06-11 |
| US20020055467A1 (en) | 2002-05-09 |
| WO2002072826A2 (en) | 2002-09-19 |
| CA2440767A1 (en) | 2002-09-19 |
| DK1930439T3 (da) | 2011-08-29 |
| SI1930439T1 (sl) | 2011-09-30 |
| DK1373503T3 (da) | 2008-03-25 |
| JP2004531242A (ja) | 2004-10-14 |
| PT1930439E (pt) | 2011-07-25 |
| EP1373503B1 (en) | 2007-11-14 |
| PT1373503E (pt) | 2008-02-26 |
| HK1120556A1 (en) | 2009-04-03 |
| WO2002072826A3 (en) | 2003-04-10 |
| ATE378353T1 (de) | 2007-11-15 |
| AU2002240943B2 (en) | 2007-05-10 |
| EP1373503A2 (en) | 2004-01-02 |
| DE60223511T2 (de) | 2008-10-23 |
| DE60223511D1 (de) | 2007-12-27 |
| CN1268744C (zh) | 2006-08-09 |
| SI1373503T1 (sl) | 2008-04-30 |
| ES2296899T3 (es) | 2008-05-01 |
| ES2366610T3 (es) | 2011-10-21 |
| JP2005198656A (ja) | 2005-07-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1111750T1 (el) | Νευροτροφικοι παραγοντες | |
| ATE522609T1 (de) | Neurotrophe faktoren | |
| NO20041917D0 (no) | Spesifikke midler som binder humant angiopoietin-2 | |
| ATE411082T1 (de) | Neue verwendung von kurzkettigen carbonsäuren | |
| PT1015585E (pt) | Homologos de ligandos de tie | |
| BR0012759A (pt) | Neurotoxinas recombinantes ativáveis | |
| EA200400510A1 (ru) | Агенты, специфически связывающие ангиопоэтин-2 | |
| IS8016A (is) | Prótín sem bindast viðtaka NOGO | |
| DE60227718D1 (de) | Verwendung von 2-Fuoro-3-Ketoestern zur Herstellung von 3-Fuoro-6,7,8,9-tetrahydro-4H-pyrimidoÄ1,2-aÜpyrimidin-4-onen | |
| ATE309356T1 (de) | Konstruierte fluoreszenzproteine mit langen wellenlängen | |
| EA200600042A1 (ru) | Способы образования дисульфидных связей и гликозилирования белков и реагенты, применяемые в этих способах | |
| EA200400392A1 (ru) | Связывающий каспазу-8 белок, его получение и применение | |
| DE10108995A1 (de) | Substituierte Pyrimidinon-Derivate als Liganden von Integrinrezeptoren | |
| DE60200162D1 (de) | Härtungszusammensetzung | |
| EA200100110A1 (ru) | Нейротрофические факторы | |
| DE60211227D1 (de) | Androgenrezeptor-Komplex assoziiertes Protein | |
| DE60217720D1 (de) | Kurkumin-zusammensetzung zur heilung von dickdarmpolypen | |
| WO2001021794A3 (en) | Smad associating polypeptides |